VHP-32407-86573 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-28
Dose 1 — Moderna
2020-12-29
Registered in v-safe
2020-12-29
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2020-12-30
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain, Redness, Swelling · None

Adult check-in
2020-12-31
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Swelling, Itching · None

Adult check-in
2021-01-01
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-02
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-03
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-04
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-01-11
Survey response — day 14, dose 1
MedDRA: Injection site erythema, Vaccination site pruritus, Vaccination site swelling — Feeling: Good

Free text: Redness, swelling, and pruritus at the vaccination site developed 1/5/21 and persisted until 1/8/21

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-18
Health check-in — day 21, dose 1
Feeling: Good

Adult check-in
2021-01-25
Dose 2 — Moderna
2021-01-25
Health check-in — day 0, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-01-26
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness

Adult check-in
2021-01-27
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-01-28
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-01-29
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Headache

Adult check-in
2021-01-30
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Itching · None

Adult check-in
2021-01-31
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-02-01
Health check-in — day 7, dose 2
Feeling: Fair · Headache

Adult check-in
2021-02-08
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-15
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-22
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-03-01
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-03-08
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-26
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-07-26
Survey response — 6 months, dose 2
MedDRA: Headache, Idiopathic intracranial hypertension, Unevaluable event — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Symptoms: Diagnosed with idiopathic intracranial hypertension due developiny an intractable positional headache · Healthcare visit (other): Procedure and imaging

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-07-26
Report sent to call center — 6 months, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-07-27
Call 1 — Left Voicemail
2021-07-27
Callback requested for
2021-07-27
Call successful
Participant prefers to complete VAERS report online
2021-11-11
Dose 3 — Moderna
2022-01-25
Health check-in — 12 months, dose 2
Feeling: Good

Adult check-in
2022-05-12
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in
2022-09-15
Dose 4 — Pfizer-BioNTech
2022-09-21
Health check-in — days 1–6 daily, dose 4
Feeling: Good · None

Adult check-in
2022-09-22
Health check-in — day 7, dose 4
Feeling: Good · Rash, not including the immediate area around the injection site

Adult check-in
2022-09-29
Health check-in — day 14, dose 4
Feeling: Good

Adult check-in
2022-10-06
Health check-in — day 21, dose 4
Feeling: Good

Adult check-in
2022-10-13
Health check-in — day 28, dose 4
Feeling: Good

Adult check-in
2022-10-20
Health check-in — day 35, dose 4
Feeling: Good

Adult check-in
2022-10-27
Health check-in — day 42, dose 4
Feeling: Good

Adult check-in
2022-12-15
Health check-in — 3 months, dose 4
Feeling: Good

Adult check-in
2023-03-16
Health check-in — 6 months, dose 4
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-28	Moderna
2	2021-01-25	Moderna
3	2021-11-11	Moderna	No
4	2022-09-15	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2021-07-26	Successful 2021-07-27	Participant prefers to complete VAERS report online

Free text

Release 1 — day 14, dose 1

2021-01-11

Symptoms: Redness, swelling, and pruritus at the vaccination site developed 1/5/21 and persisted until 1/8/21

Release 9 — 6 months, dose 2

2021-07-26

Symptoms: Diagnosed with idiopathic intracranial hypertension due developiny an intractable positional headache

Healthcare visit (other): Procedure and imaging

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Unevaluable event	✓	·	✓
SD	Headache	✓	·	✓
SD	Idiopathic intracranial hypertension	✓	·	✓
SD	Injection site erythema	✓	✓	✓
SD	Vaccination site pruritus	✓	✓	✓
SD	Vaccination site swelling	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release